טוען...
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
BACKGROUND: Treatment with angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is used to reduce proteinuria and retard the progression of chronic kidney disease (CKD). However, resolution of proteinuria may be incomplete with these therapies and the addition of a...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2020
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094274/ https://ncbi.nlm.nih.gov/pubmed/33107592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007004.pub4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|